1. Home
  2. KLXE vs BOLD Comparison

KLXE vs BOLD Comparison

Compare KLXE & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • BOLD
  • Stock Information
  • Founded
  • KLXE 2018
  • BOLD 2018
  • Country
  • KLXE United States
  • BOLD United States
  • Employees
  • KLXE N/A
  • BOLD N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • BOLD
  • Sector
  • KLXE Energy
  • BOLD
  • Exchange
  • KLXE Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • KLXE 90.4M
  • BOLD 81.0M
  • IPO Year
  • KLXE N/A
  • BOLD 2024
  • Fundamental
  • Price
  • KLXE $4.51
  • BOLD $2.95
  • Analyst Decision
  • KLXE Hold
  • BOLD Strong Buy
  • Analyst Count
  • KLXE 1
  • BOLD 3
  • Target Price
  • KLXE $4.50
  • BOLD $23.00
  • AVG Volume (30 Days)
  • KLXE 92.5K
  • BOLD 57.8K
  • Earning Date
  • KLXE 11-04-2024
  • BOLD 11-11-2024
  • Dividend Yield
  • KLXE N/A
  • BOLD N/A
  • EPS Growth
  • KLXE N/A
  • BOLD N/A
  • EPS
  • KLXE N/A
  • BOLD N/A
  • Revenue
  • KLXE $769,700,000.00
  • BOLD N/A
  • Revenue This Year
  • KLXE N/A
  • BOLD N/A
  • Revenue Next Year
  • KLXE $3.17
  • BOLD N/A
  • P/E Ratio
  • KLXE N/A
  • BOLD N/A
  • Revenue Growth
  • KLXE N/A
  • BOLD N/A
  • 52 Week Low
  • KLXE $4.18
  • BOLD $2.82
  • 52 Week High
  • KLXE $12.13
  • BOLD $15.24
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 33.44
  • BOLD N/A
  • Support Level
  • KLXE $4.31
  • BOLD N/A
  • Resistance Level
  • KLXE $4.59
  • BOLD N/A
  • Average True Range (ATR)
  • KLXE 0.31
  • BOLD 0.00
  • MACD
  • KLXE -0.05
  • BOLD 0.00
  • Stochastic Oscillator
  • KLXE 8.92
  • BOLD 0.00

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: